EuMederis Pharmaceuticals - Crunchbase Company Profile & Funding

Overview

EuMederis Pharmaceuticals

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About EuMederis Pharmaceuticals

CB Rank

713465

EuMederis Pharmaceuticals is a seed-phase drug discovery company that designs and develops peptide pharmaceuticals.

Founded

obfuscation

Private

Sugar Land, Texas, United States

1-10

eumederis.com

Biotechnology

Health Care

Pharmaceutical

Details

Legal Name

EuMederis Pharmaceuticals, Inc.

Operating Status

Active

Company Type

For Profit

Phone Number

858.967.4235

Contact Email

jnestor@eumederis.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

EuPort™ Technology Platform

A proprietary technology platform that modifies peptides with glycolipids to improve bioavailability, protease protection, therapeutic index, and duration of action.

EuPort™-Modified PTHrP Analogs for Osteoporosis and Hypoparathyroidism

Peptide analogs modified with EuPort™ designed to improve bioavailability and provide smooth, prolonged pharmacokinetic profiles for bone density treatment and hypoparathyroidism.